Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2001
08/02/2001WO2001055106A2 Novel melanocortin receptor agonists and antagonists
08/02/2001WO2001055093A1 N-arylhydrazide compounds and use thereof as drugs
08/02/2001WO2001055066A2 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
08/02/2001WO2001014330A3 Phenylpiperazines as serotonin reuptake inhibitors
08/02/2001WO2000076971A3 Serine protease inhibitors
08/02/2001WO2000036151A9 A heterogeneous assay for pyrophosphate detection
08/02/2001US20010011139 Polynucleotides labeled with dibenzorhodamine dyes
08/02/2001US20010011136 Anticancer agents
08/02/2001US20010011135 Anticancer agents
08/02/2001US20010011134 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
08/02/2001CA2398728A1 Novel melanocortin receptor agonists and antagonists
08/02/2001CA2396912A1 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
08/02/2001CA2394292A1 Isatine derivatives with neurotrophic activity
08/01/2001EP1120161A1 High molecular weight ligands for homogeneously soluble asymmetric hydrogenation catalysts, process for their preparation and use thereof
08/01/2001EP1120114A2 Compositions and methods for treating conditions responsive to estrogen
08/01/2001EP1119562A1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/01/2001EP1119550A1 2-substituted heterocyclic sulfonamides
08/01/2001EP1119549A1 Process for preparing 4-substituted-1h-indole-3-glyoxamides
08/01/2001EP1119546A1 Process for preparing toluenesulfinates
08/01/2001EP1119544A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators
08/01/2001EP1119543A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
08/01/2001CN1306510A Optical active tetrahydrobenzindole derivatives
08/01/2001CN1306422A Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for treatment or prevention of diseases characterized by abnormal cell proliferation
08/01/2001CN1306415A Colorant for colouring keratin fibres
08/01/2001CN1305994A Tert-butyl (3R, 5R)-3,5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and application
08/01/2001CN1069095C Method of systhesizing diphenylamine from aniline
07/2001
07/31/2001US6268520 Used forpreparation of optically active or racemic colchicine and thiocolchicine derivatives
07/31/2001US6268512 Heating propionylphenylhydrazide in presence of calcium oxide in solvent to produce 3-methyl-2-oxoindoline
07/31/2001US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
07/31/2001US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
07/26/2001WO2001053527A1 Method of detecting dna by dna hybridization method with the use of fluorescent resonance energy transfer
07/26/2001WO2001053292A1 Dendrimer precursor dyes for imaging
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO2001053251A1 Process for producing 3-nitro-2-(mono-substituted)aminobenzoic acid ester
07/26/2001WO2001052876A1 Ophthalmic compositions for treating ocular hypertension
07/26/2001WO2001052745A1 Novel dyes
07/26/2001WO2001052743A1 Tunable indocyanine dyes for biomedical applications
07/26/2001US20010009963 By storing a tryptophan solution at basic pH and at a temperature of room temperature to 100 degrees Celcius for 0.5 hour to 1 week, followed by crystallization; obtain spherical crystals of large particle size
07/26/2001US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress
07/26/2001DE10002976A1 Molekulargewichtsvergrößerte Liganden für asymmetrische homogen lösliche Hydrierkatalysatoren, Verfahren zu deren Herstellung und Verwendung Molecular weight-ligands for asymmetric homogeneous hydrogenation catalysts soluble, to processes for their preparation and use
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2396319A1 Ophthalmic compositions for treating ocular hypertension
07/25/2001EP1118907A2 Photographic element containing nitrogen heterocycle substituted cyan coupler, compound and process
07/25/2001EP1118323A2 Method of reducing morbidity and the risk of mortality
07/25/2001EP1117663A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
07/25/2001EP1117641A1 Indolin derivatives as sun protection agents
07/25/2001EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
07/25/2001EP1117627A1 Transfer hydrogenation process
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders
07/25/2001CN1305460A Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole
07/25/2001CN1305459A Process for preparing 4-substituted-1H-indoles-3-glyoxamides
07/25/2001CN1305124A Photo sensitive resin composition
07/25/2001CN1068882C Process for preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds
07/24/2001US6265591 Process for preparing 4-substituted-1h-indole-3-glyoxamides
07/24/2001US6265581 Reacting specified epoxide and amine, reacting product with acid to form acid addition salt
07/24/2001US6265431 Cycloalkano-indole and -azaindole derivatives
07/24/2001US6264920 Tunable indocyanine dyes for biomedical applications
07/24/2001US6264919 Restoring fluorescence; adding biocompatible solvent
07/24/2001CA2331993A1 Molecular weight-enlarged ligands for asymmetric, homogeneously soluble hydrogenation catalysts, process for the production thereof and use
07/24/2001CA2331847A1 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
07/24/2001CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001051467A1 Indole derivatives as mcp-1 receptor antagonists
07/19/2001WO2001051466A1 Indole derivatives as mcp-1 receptor antagonists
07/19/2001WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001044172A8 Salicylamides as serine protease and factor xa inhibitors
07/19/2001WO2001005791A3 NEW PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-cis-[2-(4-MORFOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'-[H]INDOL]-1'(2'H)-yl]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS
07/19/2001WO2001005760A3 New process for the preparation of spiro [(4-cyclohexanone)-[3h]indol]-2'[1'h]-one derivatives
07/19/2001WO2001005759A3 Process for the preparation of spiro-[cis-4-(beta-hydroxyethyloxy)cyclohexane-(3h) indol)-2'(1'h)-one derivatives
07/19/2001WO2001005758A3 Indoles and indazoles for the treatment of migraine
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001WO2000076966A3 Indolinylamide derivatives and the use thereof as antiviral drugs
07/19/2001US20010008901 Nitrile derivatives that inhibit cathepsin K
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/19/2001CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases
07/19/2001CA2393597A1 Indole derivatives as mcp-1 receptor antagonists
07/19/2001CA2393592A1 Indole derivatives as mcp-1 receptor antagonists
07/18/2001EP1115704A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001CN1304407A N-aryloxyethyl-indoly-alkylamines for treatment of depression
07/18/2001CN1304403A N-aryloxyethyl-indoly-alkylamines for treatment of depression (5-HT1A receptor active agents)
07/18/2001CN1304402A Sulfonamide derivatives
07/18/2001CN1304401A Calcilytic compounds
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1303859A Carbazole derivatives their preparing process and pharmaceutical composition containing them
07/18/2001CN1068588C 1H-indole-3-acetamide splA2 inhibitors
07/17/2001US6262295 Process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative
07/17/2001US6262272 Reacting furan carboxylic acid derivative with acid chloride or acid anhydride in inert solvent containing acid receptor; adding aromatic amine compound to form pyrrole carboxamide compound
07/17/2001US6262271 ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins
07/17/2001US6262114 Leukotriene B4 antagonist compounds and method for treatment
07/17/2001US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
07/17/2001US6262087 Indane or dihydroindole derivatives
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation